文献速递妇科

术前计算机断层扫描与CA-125预测晚期上皮性卵巢癌初次减灭术肉眼残留病灶的多中心评估

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2017-02-14

这项前瞻性、非随机、多中心试验的二次事后分析纳入350例III-IV期上皮性卵巢癌患者,评估术前CT与CA-125预测初次减灭术肉眼残留病灶的能力,识别出11项相关标准并建立预测模型,总评分与残留病灶率呈正比,作者认为该模型可能有助于治疗规划。

要点

  • 完全肉眼切除率为33%。
  • 多因素分析中3项临床和8项影像学标准与任何残留病灶显著相关(所有OR的P<0.01)。
  • 总评分0-2、3-5、6-8和≥9分的任何残留病灶率分别为45%、68%、87%和96%。

核心结论

  • 识别出11项与残留病灶相关的标准,并建立预测模型,其中任何残留病灶率与预测评分直接成正比;该模型可能有助于治疗规划。

研究设计与样本

  • 前瞻性、非随机、多中心试验的二次事后分析;2001年7月至2012年12月,350例符合纳入标准的III-IV期上皮性卵巢癌初次减灭术患者。

主要发现

  • 完全肉眼切除率为33%。
  • 多因素分析中与任何残留病灶显著相关的标准:年龄≥60岁(OR=1.5);CA-125≥600U/mL(OR=1.3);ASA 3-4(OR=1.6);肠系膜上动脉根部病灶(OR=4.1);脾门/脾韧带病灶(OR=1.4);小网膜囊>1cm(OR=2.2);胃肝韧带/肝门(OR=1.4);胆囊窝/段间裂(OR=2);肾上腹膜后淋巴结(OR=1.3);小肠粘连/增厚(OR=1.1);中-重度腹水(OR=2.2);所有OR的P<0.01。
  • 总评分0-2、3-5、6-8和≥9分的任何残留病灶率分别为45%、68%、87%和96%。

临床怎么用

  • 作者认为该预测模型可能有助于治疗规划。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease (RD) at primary cytoreduction in advanced ovarian cancer. METHODS: A prospective, non-randomized, multicenter trial of patients who underwent primary debulking for stage III-IV epithelial ovarian cancer previously identified 9 criteria associated with suboptimal (>1cm residual) cytoreduction. This is a secondary post-hoc analysis looking at the ability to predict any RD. Four clinical and 18 radiologic criteria were assessed, and a multivariate model predictive of RD was developed. RESULTS: From 7/2001-12/2012, 350 patients met eligibility criteria. The complete gross resection rate was 33%. On multivariate analysis, 3 clinical and 8 radiologic criteria were significantly associated with the presence of any RD: age≥60years (OR=1.5); CA-125≥600U/mL (OR=1.3); ASA 3-4 (OR=1.6); lesions in the root of the superior mesenteric artery (OR=4.1), splenic hilum/ligaments (OR=1.4), lesser sac >1cm (OR=2.2), gastrohepatic ligament/porta hepatis (OR=1.4), gallbladder fossa/intersegmental fissure (OR=2); suprarenal retroperitoneal lymph nodes (OR=1.3); small bowel adhesions/thickening (OR=1.1); and moderate-severe ascites (OR=2.2). All ORs were significant with p<0.01. A 'predictive score' was assigned to each criterion based on its multivariate OR, and the rate of having any RD for patients who had a total score of 0-2, 3-5, 6-8, and ≥9 was 45%, 68%, 87%, and 96%, respectively. CONCLUSIONS: We identified 11 criteria associated with RD, and developed a predictive model in which the rate of having any RD was directly proportional to a predictive score. This model may be helpful in treatment planning.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Suidan RS, Ramirez PT, Sarasohn DM, et al. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecol Oncol. 2017. PMID: 28209497. doi:10.1016/j.ygyno.2017.02.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。